Crinetics Pharmaceuticals CRNX
€ 51.46
1.25%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Crinetics Pharmaceuticals Bargeldumlauf 2011-2024 | CRNX
Bargeldumlauf Jährlich Crinetics Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operativer Cashflow |
-166 M | -115 M | -88.6 M | -62 M | -46.4 M | -19.5 M | -9.48 M | -5.47 M | - | - | - | - | - |
Abschreibung & Amortisation |
1.1 M | 983 K | 922 K | 948 K | 887 K | 471 K | 128 K | 92 K | - | - | - | - | - |
Kreditorenbuchhaltung |
6.55 M | 6.88 M | 3.42 M | - | - | 1.46 M | - | - | - | - | - | - | - |
Accounts Erhaltbar |
3.1 M | 1.4 M | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine Reserven |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bargeldumlauf Vierteljährlich Crinetics Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operativer Cashflow |
- | - | -52.9 M | - | - | - | -40.7 M | - | -80 M | -41.5 M | -13.5 M | - | -65.7 M | -40 M | -20.1 M | - | -46.1 M | -28.1 M | -12.2 M | - | -32.9 M | -19.3 M | -6.76 M | - | -13.4 M | -7.76 M | -3.41 M | - | -6.97 M | -4.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Abschreibung & Amortisation |
- | - | 474 K | - | - | - | 283 K | - | 703 K | 455 K | 240 K | - | 687 K | 454 K | 224 K | - | 723 K | 479 K | 235 K | - | 658 K | 430 K | 200 K | - | 263 K | 124 K | 48 K | - | 80 K | 52 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kreditorenbuchhaltung |
4.94 M | 8.87 M | 10.8 M | 6.55 M | 5.84 M | 4.84 M | 5.9 M | 6.88 M | 5.88 M | 9.04 M | - | 3.42 M | - | - | - | - | - | - | - | - | 2.11 M | 2.7 M | 2 M | 1.46 M | 1.4 M | 1.46 M | 1.46 M | 403 K | 403 K | 403 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Erhaltbar |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine Reserven |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung